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Summary
Objective—Epilepsy surgery is the most effective treatment for select patients with drug-
resistant epilepsy. In this article, we aim to provide an accurate understanding of the current 
epidemiologic characteristics of this intervention, as this knowledge is critical for guiding 
educational, academic, and resource priorities.
Methods—We profile the practice of epilepsy surgery between 1991 and 2011 in nine major 
epilepsy surgery centers in the United States, Germany, and Australia. Clinical, imaging, surgical, 
and histopathologic data were derived from the surgical databases at various centers.
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Results—Although five of the centers performed their highest number of surgeries for mesial 
temporal sclerosis (MTS) in 1991, and three had their highest number of MTS surgeries in 2001, 
only one center achieved its peak number of MTS surgeries in 2011. The most productive year for 
MTS surgeries varied then by center; overall, the nine centers surveyed performed 48% (95% 
confidence interval [CI] −27.3% to −67.4%) fewer such surgeries in 2011 compared to either 1991 
or 2001, whichever was higher. There was a parallel increase in the performance of surgery for 
nonlesional epilepsy. Further analysis of 5/9 centers showed a yearly increase of 0.6 ± 0.07% in 
the performance of invasive electroencephalography (EEG) without subsequent resections. 
Overall, although MTS was the main surgical substrate in 1991 and 2001 (proportion of total 
surgeries in study centers ranging from 33.3% to 70.2%); it occupied only 33.6% of all resections 
in 2011 in the context of an overall stable total surgical volume.
Significance—These findings highlight the major aspects of the evolution of epilepsy surgery 
across the past two decades in a sample of well-established epilepsy surgery centers, and the 
critical current challenges of this treatment option in addressing complex epilepsy cases requiring 
detailed evaluations. Possible causes and implications of these findings are discussed.
Keywords
Epilepsy surgery; Mesial temporal sclerosis; Neocortical epilepsy; Invasive EEG
Mesial temporal lobe epilepsy (m-TLE) has traditionally been equated with the prototype of 
drug-resistant focal epilepsy. When a randomized clinical trial compared surgical to medical 
therapy for drug-resistant seizures, patients with TLE were the chosen study subjects.1 
Major epilepsy advocacy groups declare TLE as the most common form of localization-
related epilepsy.2 The bulk of epilepsy research funding focuses around TLE in general, and 
m-TLE in particular.3 Against this landscape dominated by a perception of TLE as the 
central driver of the drug-resistant epilepsy burden, multiple recent anecdotal reports and 
informal surveys4–6 have implied a decline in the practice of resective surgery in the context 
of TLE. Therefore, an accurate assessment of “perception” versus “reality” becomes critical 
for multiple reasons ranging from prioritization of resource allocation to developing patient 
management strategies.
The current mechanisms of formal large-scale data assessments for epilepsy surgery 
practices and volumes are limited. In the United States, the often-used Nationwide Inpatient 
Sample does not distinguish between temporal and extratemporal resections, so 
differentiating practice patterns between the two surgery types is impossible.7 Self-reported 
data from the National Association of Epilepsy Centers are challenging given variation both 
in the type of centers included and the nature of information collected over time, as this 
valuable database was designed for administrative goals rather than as a rigorous scientific 
research tool.8,9 We present here a large-scale, comprehensive, and systematic survey 
assessing epilepsy surgery practices across the last two decades at major epilepsy centers in 
the United States, Europe, and Australia. The survey was intended to provide a valid and 
objective measurement of the current state of epilepsy surgery to guide future practice and 
research priorities.
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Methods
Patient population
Ten individual comprehensive epilepsy centers with a long tradition in epilepsy surgery 
participated in this survey. These included Cleveland Clinic, Mayo Clinic – Rochester, New 
York University, Thomas Jefferson University/Graduate Hospital, Yale University, 
University of Alabama – Birmingham, and University of California Los Angeles from the 
United States; University of Bonn from Germany; and Austin Health & Royal Melbourne 
Hospital, The University of Melbourne from Australia. Data from the latter two University 
of Melbourne centers were combined into one “Melbourne Centre,” making a total of nine 
participating epilepsy centers. These centers were selected because they have well-
established comprehensive epilepsy surgery programs, with international reputations, and 
maintain accurate prospective patient records on their epilepsy surgeries. Centers reviewed 
their epilepsy surgery research databases for clinical, surgical, and imaging patient 
characteristics for three milestone years (1991, 2001, and 2011). Only patients 12 years or 
older were included. Data collected included age at surgery, gender, magnetic resonance 
imaging (MRI) findings, histopathologic results, and the number and type of epilepsy 
surgeries. Centers performed en bloc resections of the hippocampus throughout the duration 
of the study. Overall, data collection was complete in all the surgical databases except for 
Center 6, which did not collect information on histopathology.
Study variable definitions
MRI and histopathologic findings were classified as showing evidence of mesial temporal 
sclerosis (MTS) versus not; clear other pathologies such as tumors, cortical malformations, 
or not; any abnormalities versus completely normal. The types of surgery were categorized 
into anteromedial temporal resections for m-TLE, neocortical temporal lobe resection, 
temporal lobectomy-not specified (anterior temporal lobe resection [ATL]), amygdalo-
hippocampectomy, extratemporal resections, hemispherectomy, corpus callosotomy, subpial 
transection, multilobar resections, and invasive EEG evaluations without a subsequent 
resection.
Statistical methods
Variables of interest including total numbers of all surgeries and total numbers of ATL and 
proportions of m-TLE-related surgeries were described for 1991, 2001, and 2011. 
Comparison of the change in total and MTS-related surgeries were performed using paired t-
tests. In addition to the three milestone dates, six study centers provided complete study data 
for annual or bi-annual intervals spanning the study period (1991–2011), facilitating more 
detailed trend analyses. These comprised Cleveland Clinic, Mayo Clinic, NYU, Thomas 
Jefferson University, Yale, and Melbourne. Using this more detailed dataset, we performed 
multivariate Poisson regression for MTS rates adjusting for center. The exposure for this 
model was set as the total number of surgeries per center per year. All statistical analyses 
were performed using Stata 13.1 (StataCorp, College Station, TX, U.S.A.).
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Results
The nine study centers contributed 1,346 patients (mean 149 patients/center; standard 
deviation of 77 patients; median 114 patients/center). Table 1 illustrates the main staffing 
changes observed in the study centers between 1991 and 2011. In Figure 1, the variation in 
the total number of epilepsy surgeries across the three milestone dates (A) is further detailed 
into the variation in the total number of MTS-related surgeries (C) and the variation in the 
number of surgery patients with nonlesional epilepsy (E). Overall, Figure 1 suggests a 
reduction in the number of MTS-related surgeries between 1991 and 2011, and an increase 
in the number of nonlesional surgical patients. In fact, when the practice of MTS-related 
surgery was considered in detail (Fig. 2), five of the centers performed their highest number 
of surgeries for mesial temporal sclerosis (MTS) in 1991, three had their highest number of 
MTS surgeries in 2001, and only one center achieved its peak number of MTS surgeries in 
2011. Although the most productive year for MTS surgeries varied then by center, overall, 
the nine centers surveyed performed 48% (95% confidence interval [CI] −27.3% to −67.4%) 
fewer such surgeries in 2011 compared to either 1991 or 2001, whichever was higher. There 
was a corresponding trend toward reduction in total number of epilepsy surgeries in 2011 
compared to the peak value, but this was less than the reduction in MTS surgeries (mean 
change from peak year = −25.2%, 95% CI −49.2 to +1.0%, p = 0.1) The Poisson regression 
demonstrated a significant reduction in the annual number of MTS cases per center over 
time (decline of 0.58 cases/year; p < 0.001; Fig. 3). In addition, over the same time interval 
in centers 1–5 (implant without resection data were unavailable from center 6), the 
proportion of patients undergoing intracranial EEG implantation without subsequent 
resection increased 3.3 fold: when adjusted for center, the increase was 0.7%/year, p < 0.001 
(Fig. S1).
In summary (Figs. 1–3), although MTS was the main surgical substrate in 1991 and 2001 
(proportion of total resections was 42.6 ± 22.8% and 36.5 ± 12.4%, respectively), it 
occupied only 30.5 ± 10.7% of all resections in 2011. Correspondingly, the mean proportion 
of nonlesional cases increased from 22.0 ± 11.2% in 1991 to 33.1 ± 22.2% in 2011.
Discussion
The international effort presented here provides a longitudinal description of the evolution of 
epilepsy surgery practices across the last two decades in nine selected major surgical 
epilepsy centers across the United States, Germany, and Australia. Three main “evolutionary 
processes” defining the current face of epilepsy surgery can be hypothesized:
1. The practice of m-TLE surgery is decreasing in major surgical epilepsy 
centers:
Potential explanations are the following:
a. The practice of m-TLE-related surgery is actually not 
decreasing: this is a purely artificial finding due to an 
increasing number of extratemporal surgeries leading to a 
relative drop in the proportion of all surgeries attributed to 
m-TLE. The gradual concurrent reduction in the absolute 
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numbers of m-TLE-related surgery (Fig. 1) performed in 
our centers strongly argues against this possibility and 
favors a true drop in practice. In fact, this drop in absolute 
numbers is even more striking, considering that it 
progressively decreased over time, even though each one 
of these surgical centers was becoming more established 
and gaining in reputation as a referral center.
b. The practice of m-TLE-related surgery is indeed 
decreasing in major epilepsy centers, but this is merely a 
reflection of varying referral patterns with “simpler” m-
TLE-related surgeries occurring in local hospitals instead. 
This is a critical hypothesis to entertain given the sample 
bias in our survey. The cohort reported here represents a 
select group of likely the most complex epilepsy surgery 
cases, evaluated in specialized centers, potentially 
underrepresenting easily recognizable MTS cases operated 
on locally in private practice groups or smaller academic 
epilepsy programs. Barriers to care10,11 and disparities in 
access to epilepsy surgery12,13 may restrict the choices of 
patients with drug-resistant epilepsy or simply direct them 
to obtain care locally. However, recent data from the 
Nationwide Inpatient Sample demonstrated a gradual 
overall national reduction in the practice of epilepsy 
surgery within the United States, across all hospitals and 
levels of care.7 This concerning overall reduction in 
surgical numbers, the continuing long epilepsy duration 
and high number of anticonvulsant trials prior to epilepsy 
surgery10 emphasize the ever-urgent need for early 
identification and referral of patients with drug-resistant 
epilepsy for possible surgical evaluation. However, in our 
study here we found the same pattern of reduced m-TLE 
surgery in Bonn and in Australia, countries with different 
healthcare systems and referral patterns. Such a ubiquitous 
observation of a reduction in m-TLE–related surgeries 
suggests that although a redistribution hypothesis is 
possible, it is unlikely to be the only answer.
c. The last hypothesis is that the practice of m-TLE-related 
surgery is indeed decreasing because the epidemiology of 
drug-resistant epilepsy is shifting, and there is now a 
“smaller pool” of drug-resistant epilepsy patients with 
hippocampal sclerosis as their epilepsy substrate. Under 
this assumption, every geographic area’s local patients 
with hippocampal sclerosis represent a prevalent pool that 
is efficiently surgically treated by local surgical epilepsy 
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center(s), but inefficiently replenished due to various 
factors, including an insidious course of intractability,14–16 
and better treatment of m-TLE risk factors such as 
infections and complex febrile seizures with anti-
inflammatory medications.17–19 Additional evidence 
supporting this hypothesis include recent data 
demonstrating that in addition to a reduction in numbers of 
MTS cases receiving surgery, the age at surgery is 
increasing, suggesting a diminishing supply of younger 
MTS cases.17
2. There is an increase in the practice of extratemporal resections, 
particularly in the context of surgery for nonlesional epilepsy (Fig. 1E,F): 
Potential drivers for this include better diagnostic techniques and 
neuroimaging modalities facilitating localization of the epileptogenic zone 
extratemporally,20–22 the improved noninvasive functional assessment 
tools allowing better risk-adjustment such as diffusion tensor imaging for 
mapping of visual and motor fibers,23 and the growing literature about 
possible favorable seizure freedom outcomes for extratemporal lobe 
surgery.24–33 It is interesting to observe that although this general trend 
was true for the cohort as a whole, it was not observed uniformly across 
centers (Fig. 1E), reflecting varying comfort levels and opinions about 
appropriateness of surgery in this challenging patient population that may 
obtain substantial benefit from early surgery.32
3. The use of invasive EEG evaluations that do not lead to subsequent brain 
resections is increasing (Fig. S1). Multiple potential explanations exist for 
these findings in 6/9 centers. A growing experience with invasive EEG 
implantations may have led to safer use of this technology and thus 
reduced the “implantation threshold,” even in patients with an anticipated 
suboptimal yield of epilepsy localization. Alternatively, as epileptologists 
encounter a mounting plethora of imaging and electrophysiologic 
techniques (ictal SPECT, PET, MEG, EEG-fMRI, etc.), it becomes easier 
to find “concordance” between any given number of these tests and thus 
formulate misleading localization hypotheses and subsequent unsuccessful 
invasive evaluations. Regardless of its causes, this finding highlights a 
very challenging situation. The decision to proceed directly to a resection 
versus perform an invasive EEG evaluation to test an epilepsy localization 
hypothesis versus to withhold surgery altogether is a very complex one: 
the choice depends on multiple factors, including the epilepsy severity, the 
risks of any neurological functional deficits with the anticipated brain 
resection, and the expertise of the surgical center in performing different 
invasive EEG techniques. Until better nonsurgical treatment options 
become available, it remains critical to use all noninvasive and invasive 
tools in our disposal to investigate the possibility of resective surgery. On 
the other hand, given the significant risk of neurological complications and 
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financial costs associated with such investigations, we need to learn how 
to better target our presurgical testing and restrict invasive EEG 
investigations to patients with a testable localization hypothesis.
Limitations
The heterogeneity of our findings is undeniable. Although a variable practice was most 
obvious in relation to management of nonlesional drug-resistant epilepsy (Fig. 1E,F), there 
was also demonstrable variation in the extent and rate of drop in the surgical MTS volumes 
among centers and over time. There are likely multiple factors accounting for this beyond 
the “availability” of MTS cases, including differences in timing of when individual surgical 
centers were established, variations in staffing over time within a surgical center, disparities 
in referral and reimbursement patterns, changes in the type and number of patients evaluated 
for possible surgery, and evolving pre-surgical diagnostic tools. A newly established center 
may find a prevalent pool of nonoperated MTS cases, and as it grows will increase its 
activity. Moreover, the center may choose at any time to extend its reach in the absence of a 
local pool of surgical patients. This variability in practice and variability in overall 
presenting patient distribution over time is beyond our capability to quantify on a center by 
center basis. But the overall trend is undeniable, particularly as it was observed DESPITE an 
increase in the number of epileptologists and neurosurgeons between 1991 and 2011 in our 
study centers (Table 1) and suggests that even as a center continues its activity over time, 
eventually the number of MTS patients will decline. Such an idea is supported by 
observations already reported in multiple healthcare systems, including on the national level 
in the United States using the NIS database,7 in the United Kingdom where the number of 
children receiving surgery for epilepsy had increased annually up to, and declined after, the 
establishment of Children’s Epilepsy Surgery Service centers,34 and in Germany where an 
epidemiological analysis of 2,812 patients who had TLE surgery between 1988 and 2008 
showed an early increase in the proportion of patients with MTS during the first few years 
studied, only to subsequently demonstrate an increase in the age and duration of epilepsy in 
patients with MTS despite stable overall surgical numbers over time interpreted to suggest a 
reduction in incidence of MTS.17
Implications of findings for future research
While debating the causes of our findings is important, it is critical to advance the discussion 
further and tackle their implications. Making this leap is essential to develop the 
“evolutionary” adaptive steps that would be necessary for the betterment of the care of 
patients with drug-resistant epilepsy. Regardless of the cause, our data suggest that m-TLE 
related surgeries no longer account for the major burden of surgical epilepsy in major 
established epilepsy centers in the developed world, and an increasing number of patients 
with complex nonlesional epilepsy are being assessed/undergoing surgery. As our patient 
population is expanding in complexity, so should our clinical care resources and our research 
priorities. Given our findings, specific suggestions for future research include:
1. Thorough and systematic epidemiological research to better understand 
and improve the utilization of epilepsy surgery, for ALL potential surgical 
candidates. Such work will be critical to optimize the reach of epilepsy 
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surgery for patients in “underserved” pockets with drug-resistant m-TLE, 
and to enhance the identification of adequate surgical candidates among 
the challenging group of nonlesional patients with drug-resistant focal 
epilepsy.
2. Methodologically sound outcomes research to assess the effectiveness of 
various surgical procedures and presurgical evaluation tools given the 
observed heterogeneity among centers in their management of patients 
with nonlesional drug resistant epilepsy. This variation together with the 
increase in the number of invasive evaluations without subsequent 
resections highlight a need to improve patient selection, presurgical 
evaluation protocols, and outcomes of care in this complex surgical 
population.
3. Expanding the scope of clinical and basic science research studying extra-
temporal epilepsy given its growing contribution to the surgical epilepsy 
burden. Continuing to predominantly focus various stakeholder resources 
on m-TLE alone will fall short of addressing the present and future needs 
of surgical epilepsy.
Conclusions
We cannot overemphasize the fact that it remains critical to reach pockets of “underserved” 
epilepsy population in developed and developing countries with likely high prevalence of 
hippocampal sclerosis. Understanding/solving the barriers to care remain paramount, 
including the possibility that patient perception of disease severity and knowledge of 
treatment options is little understood. In addition, our data suggest that we also owe a 
significant effort to our patients with drug-resistant nonlesional epilepsy to better understand 
their disease, localize it, resect it safely, grasp and improve the long-term success of surgery, 
and even better, prevent the development of epilepsy. This will require major research 
efforts, but our data suggest that these efforts would seem well-justified.
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Key Points
• The practice of surgery for mesial temporal lobe epilepsy is decreasing 
in major surgical epilepsy centers
• There is an increase in the practice of extratemporal resections, 
particularly in the context of surgery for nonlesional epilepsy
• The use of invasive EEG evaluations that do not lead to subsequent 
brain resections is increasing
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Figure 1. 
Number of epilepsy surgeries reported in 1991, 2001, and 2011 for nine epilepsy centers. 
(A) Total epilepsy surgeries at each time point for individual epilepsy centers. Two centers 
(3 and 7) were not active or did not track statistics in 1991. (B) Sum of all epilepsy surgeries 
across the nine epilepsy centers for each time point. The overall number of epilepsy 
surgeries at these nine centers does not exhibit consistent trends. Some centers (2, 6, and 7) 
reported overall increases in total surgeries whereas others reported declines. (C) Number of 
MTS-related surgeries at each time point for individual centers. All but one center (7) 
reported a decline in MTS-related surgeries in 2011 compared to a prior peak in either 1991 
or 2001. (D) Sum of all MTS-related surgeries across the nine centers. Overall, there was a 
decline in total MTS-related resections in the group. (E) Number of surgeries performed for 
nonlesional epilepsy (NL) at each time point for individual centers. Five of the nine centers 
reported an increase in the number of surgeries performed for NL epilepsy in 2011 
compared to prior years. (F) Sum of all NL epilepsy–related resections across the nine 
centers. Overall, there was an increase in the number of NL epilepsy–related surgeries in 
2011.
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Figure 2. 
Plot of the percent change in total and MTS-related surgeries at each center compared to the 
peak number of surgeries (the highest value reported in the prior two time points, 1991 or 
2001). All but one center reported a decline in MTS-related surgeries in 2011 compared to 
the prior peaks. The mean change was 48.0% (95% CI −27.3 to −67.4%, blue line). 
Although most centers also reported a decline in epilepsy surgeries overall, this change was 
less pronounced (mean change −25.6%, 95% CI −51.0 to +1.0%, black line) and two centers 
reported an overall increase.
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Figure 3. 
Number of epilepsy surgeries per year for five centers that provided annual or biannual data 
from 1991 to 2011. When adjusted for center, there was an overall reduction of 0.34 MTS-
related surgeries per year (dashed line) across the two decades. This translates into a 1.3% 
reduction in MTS-related surgeries annually compared to 1991.
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